Pharmafile Logo
Pharmafocus logo
Advanced Search

Belgium

Showing 5 posts of 5 posts found.

convert-logo1

Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours

March 9, 2018
Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma

Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …

News
sanofi_hq__boetie_hall

Sanofi invests €300 million in new Belgian biologics site

April 19, 2016
Manufacturing and Production Belgium, Sanofi, belgian, flanders, geel, investment, manufacturing, pipeline

Sanofi has announced plans to expand its site in Geel, Belgium, with a €300 million investment to support its pipeline …

News

UCB sells generics business

November 10, 2014
Manufacturing and Production, Sales and Marketing Belgium, UCB, generics, kremers urban, us conern

UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …

News
UCB image

UCB opens Belgian pilot plant

September 17, 2012
Manufacturing and Production Amgen, Belgium, R&D, UCB

UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …

News

Genzyme plans new Belgium facility

January 25, 2011
Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa

US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025